🇺🇸 FDA
Patent

US 8470342

Methods of altering an immune response induced by CpG oligodeoxynucleotides

granted A61PA61P1/04A61P1/16

Quick answer

US patent 8470342 (Methods of altering an immune response induced by CpG oligodeoxynucleotides) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P1/04, A61P1/16, A61P11/02, A61P11/04